Impairment in functional status and survival in patients with acute myeloid leukaemia

Journal of Cancer Research and Clinical Oncology

Volumn 132, Issue 10, 2006, Pages 665-671

  Wedding, Ulrich ^a   Röhrig, Bernd ^a   Klippstein, Almuth ^a   Fricke, Hans Joerg ^a   Sayer, Herbert G ^a   Höffken, Klaus ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Acute myeloid leukaemia; Chemotherapy; Functional status; Geriatric assessment; Survival

Indexed keywords

CYTARABINE; ETOPOSIDE; IDARUBICIN; MITOXANTRONE; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGE DISTRIBUTION; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOGENETICS; DAILY LIFE ACTIVITY; FEMALE; FUNCTIONAL STATUS; GENETIC RISK; HUMAN; KARNOFSKY PERFORMANCE STATUS; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROME; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; UNIVARIATE ANALYSIS;

ACTIVITIES OF DAILY LIVING; ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 33748167066     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-006-0115-7     Document Type: Article

References (24)

1. Afifi AA (1984) Computer-aided multivariate analysis. Chapman & Hall/ CRC, New York
2. Altman DG (1991) Practical statistics for medical research. Chapman & Hall, London
3. Belsley DA, Kuh E, Welsch RE (1984) Regression diagnostics: identifying influential data and sources of collinearity. Wiley, New York
4. Bennett JM et al (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) cooperative group. Br J Haematol33(4):451-458
5. Byrd JC et al (2002) Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 100(13):4325-4336
6. Estey EH (2000) How I treat older patients with AML. Blood 96(5):1670-1673
7. Extermann M et al (1998) Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 16(4):1582-1587
8. Ferrara F et al (1998) Acute myeloid leukemia in the elderly: a critical review of therapeutic approaches and appraisal of results of therapy. Leuk Lymphoma 29(3-4):375-382
9. Grimwade D et al (2001) The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 98(5):1312-1320
10. Gupta V et al (2005) Disease biology rather than age is the most important determinant of survival of patients > or = 60 years with acute myeloid leukemia treated with uniform intensive therapy. Cancer 103(10):2082-2090
11. Hiddemann W et al (1999) Management of acute myeloid leukemia in elderly patients. J Clin Oncol 17(11):3569-3576
12. Hoyle CF et al (1989) AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial. Br J Haematol 72(1):45-53
13. Karnofsky DA Adelmann WH, Craver FL (1948) The use of nitrogen mustard in the palliative treatment of carcinoma. Cancer 1:634-656
14. Lawton MP Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9(3):179-186
15. Leith CP et al (1997) Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. Blood 89(9):3323-3329
16. Löwenberg B (2001) Managing therapy in older adult patients with acute myeloid leukemia. Semin Hematol 38(3 Suppl 6): 10-16
17. Matthews JP et al (2001) Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia. Br J Haematol 113(3):727-736
18. Repetto L et al (1998) Performance status and comorbidity in elderly cancer patients compared with young patients with neoplasia and elderly patients without neoplastic conditions [see comments]. Cancer 82(4):760-765
19. Reuben DB et al (1992). Value of functional status as a predictor of mortality: results of a prospective study [published errata appear in Am J Med 1993 Feb 94(2):232 and 1993 May 94(5):560]. Am J Med 93(6): 663-669
20. Ries LAG et al (2001) SEER Cancer Statistics Review, 1973-1998, National Cancer Institute. Bethesda, http://www.seer.cancer.gov/Publications/CSR1983- 1988/
21. Sekeres MA et al (2004) Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndrome. Leukemia 18(4):809-816
22. Tallman MS, Gilliland DG, Rowe JM (2005) Drug therapy of acute myeloid leukemia. Blood 106(4):1154-1163
23. Wedding U, Bokemeyer C, Meran JG (2004) Elderly patients with acute myeloid leukaemia: characteristics in biology, patients and treatment. Recommendations of the Working Group Geriatric Oncology of the German Society for Haematology and Oncology (DGHO), the Austrian Society for Haematology and Oncology (OGHO) and the German Society for Geriatrics (DGG). Onkologie 27(1):72-82
24. Zagonel V et al (2002) The comprehensive geriatric assessment (CGA) predicts mortality among elderly cancer patients (ECP). Proc Am Soc Clin Oncol 21:1458